| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1170741
[patent_doc_number] => 06753419
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'DNA molecules encoding hormone-dependent forms of the adeno-associated virus rep proteins'
[patent_app_type] => B1
[patent_app_number] => 09/554958
[patent_app_country] => US
[patent_app_date] => 2000-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11755
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753419.pdf
[firstpage_image] =>[orig_patent_app_number] => 09554958
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554958 | DNA molecules encoding hormone-dependent forms of the adeno-associated virus rep proteins | Jul 6, 2000 | Issued |
Array
(
[id] => 729212
[patent_doc_number] => 07041807
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-09
[patent_title] => 'Antibodies to a YYX epitope of a mammalian prion protein'
[patent_app_type] => utility
[patent_app_number] => 09/602775
[patent_app_country] => US
[patent_app_date] => 2000-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 15589
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/041/07041807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09602775
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/602775 | Antibodies to a YYX epitope of a mammalian prion protein | Jun 22, 2000 | Issued |
| 09/508037 | METHOD FOR PURIFYING AND CONCENTRATING AAV-2 AND ANTIGEN PORTIONS THEREOF | Jun 22, 2000 | Abandoned |
Array
(
[id] => 699684
[patent_doc_number] => 07067638
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-27
[patent_title] => 'Small round structured virus (SRSV) detection kit'
[patent_app_type] => utility
[patent_app_number] => 09/926799
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9998
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067638.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926799 | Small round structured virus (SRSV) detection kit | Jun 21, 2000 | Issued |
Array
(
[id] => 1062662
[patent_doc_number] => 06849406
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples'
[patent_app_type] => utility
[patent_app_number] => 09/926808
[patent_app_country] => US
[patent_app_date] => 2000-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7761
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849406.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926808
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926808 | Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples | Jun 15, 2000 | Issued |
Array
(
[id] => 1395657
[patent_doc_number] => 06534065
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'Influenza vaccine composition with chitosan adjuvant'
[patent_app_type] => B1
[patent_app_number] => 09/583124
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6059
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534065.pdf
[firstpage_image] =>[orig_patent_app_number] => 09583124
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/583124 | Influenza vaccine composition with chitosan adjuvant | May 29, 2000 | Issued |
Array
(
[id] => 1122224
[patent_doc_number] => 06793926
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Methods for production of a recombinant adeno-associated virus'
[patent_app_type] => B1
[patent_app_number] => 09/578561
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 21456
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/793/06793926.pdf
[firstpage_image] =>[orig_patent_app_number] => 09578561
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/578561 | Methods for production of a recombinant adeno-associated virus | May 24, 2000 | Issued |
Array
(
[id] => 1192733
[patent_doc_number] => 06730475
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-04
[patent_title] => 'Methods of diagnosis and treatment of meniere disease'
[patent_app_type] => B1
[patent_app_number] => 09/579288
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18233
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730475.pdf
[firstpage_image] =>[orig_patent_app_number] => 09579288
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/579288 | Methods of diagnosis and treatment of meniere disease | May 24, 2000 | Issued |
Array
(
[id] => 1485438
[patent_doc_number] => 06428324
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'RNA respiratory syncytial virus vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/486553
[patent_app_country] => US
[patent_app_date] => 2000-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 9473
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/428/06428324.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486553
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486553 | RNA respiratory syncytial virus vaccines | May 23, 2000 | Issued |
Array
(
[id] => 7607399
[patent_doc_number] => 07098317
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-29
[patent_title] => 'Antibodies capable to selectively detect prion PrPSc isoforms'
[patent_app_type] => utility
[patent_app_number] => 09/576724
[patent_app_country] => US
[patent_app_date] => 2000-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4944
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098317.pdf
[firstpage_image] =>[orig_patent_app_number] => 09576724
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/576724 | Antibodies capable to selectively detect prion PrPSc isoforms | May 22, 2000 | Issued |
Array
(
[id] => 6720324
[patent_doc_number] => 20030054012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE'
[patent_app_type] => new
[patent_app_number] => 09/462713
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25335
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054012.pdf
[firstpage_image] =>[orig_patent_app_number] => 09462713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462713 | PSEUDOMONAS EXOTOXIN A-LIKE CHIMERIC IMMUNOGENS FOR ELICITING A SECRETORY IGA-MEDIATED IMMUNE RESPONSE | May 11, 2000 | Abandoned |
| 09/567035 | Rapid single-cycle assay for human immunodefiency virus type 1 drug resistance | May 7, 2000 | Abandoned |
| 09/560803 | Methods and compositions for increasing viral vector production in packaging cell lines | Apr 27, 2000 | Abandoned |
Array
(
[id] => 1531094
[patent_doc_number] => 06410013
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Viral vectors for use in monitoring HIV drug resistance'
[patent_app_type] => B1
[patent_app_number] => 09/559244
[patent_app_country] => US
[patent_app_date] => 2000-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 18733
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410013.pdf
[firstpage_image] =>[orig_patent_app_number] => 09559244
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/559244 | Viral vectors for use in monitoring HIV drug resistance | Apr 25, 2000 | Issued |
Array
(
[id] => 1476739
[patent_doc_number] => 06451319
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Recombinant and mutant adenoviruses'
[patent_app_type] => B1
[patent_app_number] => 09/545481
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17862
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09545481
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/545481 | Recombinant and mutant adenoviruses | Apr 6, 2000 | Issued |
Array
(
[id] => 1311520
[patent_doc_number] => 06613742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Chemokine-derived synthetic peptides'
[patent_app_type] => B1
[patent_app_number] => 09/543940
[patent_app_country] => US
[patent_app_date] => 2000-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11604
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613742.pdf
[firstpage_image] =>[orig_patent_app_number] => 09543940
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/543940 | Chemokine-derived synthetic peptides | Apr 5, 2000 | Issued |
| 09/509856 | SUSPENSION PACKING CELL LINES FOR RETROVIRUS VECTORS | Mar 30, 2000 | Abandoned |
| 09/509239 | FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS | Mar 22, 2000 | Abandoned |
Array
(
[id] => 1465831
[patent_doc_number] => 06458350
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'ULBP DNA and polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/532856
[patent_app_country] => US
[patent_app_date] => 2000-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 31316
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458350.pdf
[firstpage_image] =>[orig_patent_app_number] => 09532856
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/532856 | ULBP DNA and polypeptides | Mar 21, 2000 | Issued |
| 09/508913 | ATTENUATED RESPIRATORY SYNCYTIAL VIRUSES | Mar 15, 2000 | Abandoned |